New: NCI-funded clinical trial search
Mednet Logo
SpecialtiesRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

What is the best IGRT strategy in treating the prostate bed (adjuvant or salvage): Daily anatomy KV images vs. fiducial seed kv images vs. CBCTs?

4
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Chicago

For our post-prostatectomy men, we use daily kV and line up to surgical clips if available (contouring out a clip each quadrant of the prostate bed if possible) with a PTV expansion of 5 mm. If clips are not present, then we use CBCT to evaluate soft tissue alignment and use a slightly larger PTV of...

Can you give Pluvicto with concurrent palliative EBRT?

9
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Corewell Health

Short answer: Yes, you can, and I do not modify my dose. I have no issues with this and have done it multiple times for patients who need more immediate symptom relief (pain, bleeding, etc.).Why? Because Pluvicto is a medium energy isotope with a relatively short path length of around 2 mm. Even nea...

What strategies do you use for large breasted women receiving whole breast radiation?

7
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

If we can't do prone, we use a styroform wedge in the inframammary region to decrease the breast fold and thus, decrease the inferior margin and amount of inframammary fold we have to treat. I would initially try hypofractionation with mixed beam with a field-in-field technique and if the dose homog...

How would you proceed when a cervical cancer undergoing brachytherapy has exceeded the rectal dose but not met the target dose?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

Rectal dose and target dose have range. Preferred rectal dose for D2cc < 65 Gy but can accept up to D2cc < 75 Gy, provided you understand expected risk of complications with increased dose. Preference would be to do hybrid applicator with 3D imaging to optimize HRCTV and OAR.

Does a history of ipsilateral breast atypia preclude APBI when otherwise suitable?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

It would not preclude APBI if otherwise suitable.

For a patient who previously underwent PBI and then developed a second ipsilateral primary, would you offer repeat PBI?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Arkansas for Medical Sciences

If this is a younger patient, I would confirm that they have negative genetic testing before considering re-irradiation, and, in any case, ideally, the management options would be discussed with the patient and surgeon prior to offering breast conservation surgery. Considerations would be the locati...

How do you approach axillary radiation in a patient with breast cancer who did not have a sentinel node biopsy?

1
4 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

Choose wisely. The message from the surgery group discourages SNLN bx in 70 and above with low to intermediate grade pathology. As far as RT is concerned, AI alone, APBI, and 5 fraction whole breast are all reasonable options in those patients, and not having SNLN would not change recommendations. T...

How would you treat an early-stage ER/PR+ Her-2 negative breast cancer s/p lumpectomy in an elderly patient who had sentinel node biopsy omission?

4
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Allegheny Health Network, Pittsburgh

I consider these patients as being managed appropriately surgically based on CALGB and current guidelines. As such, I routinely offer these patients APBI.Unless there are other features, I do not think these patients need WBRT just because they didn't have a SLN. If they are eligible for omission of...

When is the ideal time in the disease course to offer radiotherapy for Dupuytren's disease for the most optimal outcomes?

1
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Inova Schar Cancer Institute

Radiotherapy is most effective when fibroblasts are actively proliferating, i.e., during the cellular or proliferative phase of the disease, when there is a palpable, progressive nodule or cord but no fixed contracture.Prospective German trials show that treating during this biologically active peri...

Would you consider re-irradiation for recurrence of Dupuytren's Contracture?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Weatherby Health Care

I have, in fact, re-treated one patient about two years after the first course because some nodules were progressing. I did a limited electron field with bolus to cover just the affected area and gave 200 x 10. Things seemed to stabilize after that. I would not treat a third time, however, but I hav...